LENSAR® Provides Update on Pending Acquisition by Alcon

Core Viewpoint - LENSAR, Inc. is in the process of being acquired by Alcon Research, LLC, with the transaction expected to close in the first half of 2026, pending regulatory approval from the U.S. Federal Trade Commission (FTC) [2]. Company Overview - LENSAR is a commercial-stage medical device company that specializes in advanced systems for cataract treatment and astigmatism management [3]. - The company has developed the ALLY Robotic Cataract Laser System™, which integrates AI and proprietary imaging technology to enhance surgical outcomes and operational efficiency [3]. - The ALLY system is designed for use in sterile operating rooms or in-office surgical suites, aiming to transform premium cataract surgery [3].